Azenta, Inc. (NASDAQ:AZTA) Shares Bought by Royal Bank of Canada

Royal Bank of Canada grew its position in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 9.1% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 573,443 shares of the company's stock after purchasing an additional 47,936 shares during the quarter. Royal Bank of Canada owned approximately 1.25% of Azenta worth $28,673,000 as of its most recent filing with the SEC.

Several other hedge funds also recently made changes to their positions in AZTA. Picton Mahoney Asset Management grew its holdings in shares of Azenta by 305.7% during the fourth quarter. Picton Mahoney Asset Management now owns 706 shares of the company's stock worth $35,000 after purchasing an additional 532 shares during the last quarter. Headlands Technologies LLC acquired a new stake in shares of Azenta during the fourth quarter worth about $40,000. Covestor Ltd boosted its stake in shares of Azenta by 64.2% during the fourth quarter. Covestor Ltd now owns 2,043 shares of the company's stock worth $102,000 after buying an additional 799 shares during the period. KBC Group NV boosted its stake in shares of Azenta by 48.5% during the fourth quarter. KBC Group NV now owns 2,137 shares of the company's stock worth $107,000 after buying an additional 698 shares during the period. Finally, Quarry LP acquired a new stake in shares of Azenta during the fourth quarter worth about $110,000. Hedge funds and other institutional investors own 99.08% of the company's stock.

Analysts Set New Price Targets

AZTA has been the subject of several recent research reports. Evercore ISI increased their target price on shares of Azenta from $50.00 to $52.00 and gave the stock an "in-line" rating in a research note on Thursday, February 6th. TD Cowen upgraded shares of Azenta to a "hold" rating in a research note on Thursday, February 27th. Finally, Needham & Company LLC decreased their target price on shares of Azenta from $59.00 to $40.00 and set a "buy" rating for the company in a research note on Wednesday, May 7th.

Azenta Stock Performance

NASDAQ:AZTA traded up $0.72 during mid-day trading on Tuesday, reaching $27.72. The stock had a trading volume of 1,110,879 shares, compared to its average volume of 692,250. The firm has a market capitalization of $1.27 billion, a price-to-earnings ratio of -9.30 and a beta of 1.64. Azenta, Inc. has a twelve month low of $23.91 and a twelve month high of $63.58. The business has a 50 day simple moving average of $28.85 and a 200 day simple moving average of $40.81.

Azenta (NASDAQ:AZTA - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.05 EPS for the quarter, missing analysts' consensus estimates of $0.09 by ($0.04). Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. During the same quarter last year, the company posted $0.06 earnings per share. Azenta's revenue for the quarter was up 5.1% compared to the same quarter last year. As a group, sell-side analysts expect that Azenta, Inc. will post 0.53 earnings per share for the current year.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.